Biogen Inc. buy Vassago1
Start price
27.07.15
/
50%
€275.42
Target price
27.01.16
€306.69
Performance (%)
-14.89%
End price
27.01.16
€234.40
Summary
This prediction ended on 27.01.16 with a price of €234.40. The price of Biogen Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -14.89%. Vassago1 has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Biogen Inc. | 0.273% | 0.273% | 50.978% | -41.593% |
| iShares Core DAX® | 0.985% | 8.314% | 7.032% | 49.791% |
| iShares Nasdaq 100 | 2.067% | 16.765% | 35.952% | 96.632% |
| iShares Nikkei 225® | 2.270% | 15.605% | 46.568% | 69.047% |
| iShares S&P 500 | 1.043% | 11.077% | 26.456% | 68.087% |
Comments by Vassago1 for this prediction
In the thread Biogen Inc. diskutieren
NPM 36%
kurze Q3 Info:
Biogen hat Analystenerwartungen beim Umsatz u. Gewinn klar übertroffen. Die EPS Prognose wurde für das lfd. Jahr angehoben und neue Rekordumsätze bei Tecfidera, Plegridy, Alprolix, und Eloctate erzielt. NPM 35%.
http://media.biogen.com/press-release/investor-relations/biogen-third-quarter-2015-revenues-increase-11-28-billion-company-r
(Laufzeit überschritten)